Health Condition 1: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention1: Plasma rich platelets: Concentrated platelets, derived from autologous blood, are concentrated into a polymer called platelet-rich plasma (PRP). PRP has chemotactic and mitogenic proper
Sponsors
Dr Ankit
Eligibility
Inclusion criteria
Inclusion criteria: Patients with early OA knee and Kellgren and Lawrence Scale (K&L) stage I and II. Patient with persistent symptoms (pain, joint stiffness etc) irrespective of being treated with conservative treatment, including physical therapy, manipulation. Patients were not under any other treatments for Osteoarthritis in the last month besides occasional analgesics.
Exclusion criteria
Exclusion criteria: Patients with severe osteoarthritis ( K& L stage III and IV) Patient treated with long release corticosteroids infiltration over the last month Patient on immune suppresor or chemotherapy treatment Local/ general infections; patient with previous joint replacement Actue rheumatoid arthritis and rheumatoid immune diseases Low platelets (100,000) or low fibrinogen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the clinico-functional outcome of intraarticular platelet rich plasma and platelet rich fibrin in the management of early osteoarthritis of knee at 24th weekTimepoint: 24th week | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the clinico-functional outcome of intraarticular platelet rich plasma & platelet rich fibrin in the management of early osteoarthritis of knee at 2nd week, 4th week, 8th week, 12th week,24th weekTimepoint: 2nd week, 4th week, 8th week, 12th week, 24th week | — |
Countries
India
Contacts
Public ContactDr Hariprasad S
Sri Devaraj Urs Academy of Higher Education and Research
Outcome results
None listed